1. Randomized contralateral comparison of visual outcomes following implantation of two monofocal aspherical intraocular lenses after cataract surgery.
- Author
-
Zarei-Ghanavati S, Monfared N, Heravian J, Momeni-Moghaddam H, Hemmatian Z, and Wolffsohn JS
- Subjects
- Contrast Sensitivity, Humans, Lens Implantation, Intraocular, Prospective Studies, Prosthesis Design, Cataract, Lenses, Intraocular, Phacoemulsification
- Abstract
Purpose: To compare optical and visual performances of two one-piece aspherical implanted intraocular lenses (IOLs) following phacoemulsification cataract surgery in a contralateral eye study., Methods: In this prospective randomized parallel-group study, 25 patients with bilateral age-related cataract were implanted in one eye with the EnVista IOL (MX60, Bausch & Lomb Corporations, Rochester, NY, USA) and the Acrysof IQ IOL (Acrysof IQ SN60WF, Alcon Surgical Laboratories, Fort Worth, TX, USA) in the other eye. Uncorrected and corrected distance visual acuity (UDVA, CDVA), refractive status, higher-orders aberrations (HOAs) in 5 and 6 mm pupil size, contrast sensitivity (CS) with and without glare, color vision status, and patient satisfaction were assessed in the two eyes at 1 and 3 months after surgery., Results: There was no significant difference in CDVA (P > 0.99), UDVA (P = 0.46), spherical equivalent refractive error (P = 0.63), CS with and without glare across different spatial frequencies, color vision, and root mean square (RMS) of aberrometric values between the two IOLs after 3-month follow-up. Spherical aberration with 5 and 6 mm pupil sizes (P = 0.02) and horizontal coma with a 6 mm pupil size (P < 0.001) were lower with the EnVista IOL. Patient's satisfaction showed no cases of dissatisfaction, and most patients were highly or moderately satisfied with both IOLs., Conclusion: The visual and optical performance of eyes implanted with the EnVista IOL or the Acrysof IQ IOL was similar, although the aberration profile differed., (© 2021. The Author(s), under exclusive licence to Springer Nature B.V.)
- Published
- 2022
- Full Text
- View/download PDF